Wolverine Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-61
| Closed | -$6.31K | – | 1544 |
|
|
2022
Q4 | $6.31K | Sell |
61
-781
| -93% | -$80.8K | ﹤0.01% | 1329 |
|
|
2022
Q3 | $71K | Sell |
842
-1,900
| -69% | -$160K | ﹤0.01% | 1201 |
|
|
2022
Q2 | $227K | Hold |
2,742
| – | – | ﹤0.01% | 939 |
|
|
2022
Q1 | $211K | Sell |
2,742
-2,000
| -42% | -$154K | ﹤0.01% | 952 |
|
|
2021
Q4 | $418K | Sell |
4,742
-4,509
| -49% | -$397K | ﹤0.01% | 822 |
|
|
2021
Q3 | $715K | Sell |
9,251
-7,845
| -46% | -$606K | 0.01% | 649 |
|
|
2021
Q2 | $1.43M | Sell |
17,096
-2,615
| -13% | -$218K | 0.01% | 391 |
|
|
2021
Q1 | $1.49M | Buy |
19,711
+10,304
| +110% | +$778K | 0.01% | 393 |
|
|
2020
Q4 | $824K | Buy |
9,407
+3,177
| +51% | +$278K | 0.01% | 511 |
|
|
2020
Q3 | $473K | Buy |
6,230
+5,895
| +1,760% | +$448K | ﹤0.01% | 538 |
|
|
2020
Q2 | $41K | Buy |
+335
| New | +$41K | ﹤0.01% | 977 |
|
|
2019
Q3 | – | Sell |
-2,622
| Closed | -$224K | – | 1071 |
|
|
2019
Q2 | $224K | Buy |
2,622
+2,020
| +336% | +$173K | ﹤0.01% | 711 |
|
|
2019
Q1 | $53K | Buy |
+602
| New | +$53K | ﹤0.01% | 829 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1104 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1056 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 993 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 760 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 673 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 699 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 673 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 758 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 986 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1022 |
|
|
2015
Q2 | – | Sell |
-550
| Closed | -$68K | – | 1043 |
|
|
2015
Q1 | $68K | Sell |
550
-2,188
| -80% | -$271K | ﹤0.01% | 822 |
|
|
2014
Q4 | $247K | Buy |
2,738
+800
| +41% | +$72.2K | ﹤0.01% | 646 |
|
|
2014
Q3 | $139K | Buy |
1,938
+1,700
| +714% | +$122K | ﹤0.01% | 862 |
|
|
2014
Q2 | $14K | Buy |
+238
| New | +$14K | ﹤0.01% | 973 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 1127 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 1275 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 1184 |
|